calendar
79 catalysts · 3,633 phase readout · 2,052 8k filing · 276 earnings · 172 phase 2 completion · 169 grant · 133 drug shortage
next 91 dayslessmore
MonWedFri
79 catalysts · 3,633 phase readout · 2,052 8k filing · 276 earnings · 172 phase 2 completion · 169 grant · 133 drug shortage
Therapy area: Central Nervous System. Indication: Smoking Cessation
Therapy area: Immunology. Indication: Inflammation
Therapy area: Oncology. Indication: Adenocarcinoma, Endometrial Cancer, Ovarian Cancer
Therapy area: Cardiovascular, Central Nervous System, Gastrointestinal. Indication: Hypotension, Post Operative Nausea And Vomiting, Post-Operative Pain
Therapy area: Genito Urinary System. Indication: Primary Hyperoxaluria, Primary Hyperoxaluria Type I, Primary Hyperoxaluria Type II, Renal Insufficiency
Therapy area: Metabolic Disorders. Indication: Heterozygous Familial Hypercholesterolemia (heFH), Hypercholesterolemia, Mixed Dyslipidemia
Therapy area: Oncology. Indication: Solid Tumor
Therapy area: Infectious Disease. Indication: Respiratory Syncytial Virus (RSV) Infections
Therapy area: Oncology. Indication: Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis), Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Advanced Malignancy, Bladder Cancer, Esophageal Cancer, Gastric Cancer, Liver Cancer, Malignant Mesothelioma, Non-Small Cell Lung Cancer, Pancreatic Cancer, Solid Tumor
Therapy area: Oncology. Indication: Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, Cutaneous T-Cell Lymphoma, Natural Killer Cell Lymphomas, Peripheral T-Cell Lymphomas (PTCL), T-Cell Leukemia, T-Cell Lymphomas
Therapy area: Oncology. Indication: Cutaneous T-Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome
Therapy area: Oncology. Indication: Breast Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Non-Small Cell Lung Cancer, Solid Tumor
Therapy area: Immunology. Indication: Inflammation
Therapy area: Oncology. Indication: Colorectal Cancer, Gastric Cancer, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer
Therapy area: Oncology. Indication: Metastatic Pancreatic Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
Therapy area: Central Nervous System. Indication: Musculoskeletal Pain, Post-Operative Pain
Therapy area: Oncology. Indication: Advanced Malignancy, Metastatic Cancer, Solid Tumor
Therapy area: Oncology. Indication: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, Cutaneous T-Cell Lymphoma, Natural Killer Cell Lymphomas, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphomas (PTCL), Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Sezary Syndrome, T-Cell Leukemia, T-Cell Lymphomas, Transformed Mycosis Fungoides
Therapy area: Oncology. Indication: Colorectal Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Solid Tumor
Therapy area: Infectious Disease. Indication: Bacillary Dysentery (Shigellosis)
Therapy area: Cardiovascular. Indication: Cardiovascular Disease, Endothelial Dysfunction
Therapy area: Oncology. Indication: Breast Cancer, Hormone Sensitive Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Metastatic Breast Cancer
Therapy area: Oncology. Indication: Kidney Cancer (Renal Cell Cancer), Ovarian Cancer, Renal Cell Carcinoma
Therapy area: Central Nervous System. Indication: Major Depressive Disorder
Therapy area: Immunology. Indication: Anaphylaxis, Food Allergy, Peanut Allergy
Therapy area: Genito Urinary System. Indication: Renal Insufficiency
Therapy area: Metabolic Disorders. Indication: Obesity
Therapy area: Hematological Disorders. Indication: Hemophilia A (Factor VIII Deficiency)